From alveolar haemorrhage to pulmonary renal syndrome

M. Schwarz (Aurora, United States of America)

Source: Annual Congress 2011 - Vasculitis and the lung
Session: Vasculitis and the lung
Session type: Symposium
Number: 1869

Slide presentationMultimedia files

Rating: 4
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Schwarz (Aurora, United States of America). From alveolar haemorrhage to pulmonary renal syndrome. Annual Congress 2011 - Vasculitis and the lung

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

- 18.10.2011 03:56
very informative
You must Login to comment this presentation.


Related content which might interest you:
Occult alveolar haemorrhage in pulmonary veno-occlusive disease
Source: Eur Respir J 2006; 27: 108-113
Year: 2006



Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis
Source: Eur Respir J, 49 (5) 1700178; 10.1183/13993003.00178-2017
Year: 2017



Haemodynamically proven pulmonary hypertension in a patient with GATA2 deficiency-associated pulmonary alveolar proteinosis and fibrosis
Source: Eur Respir J, 49 (5) 1700407; 10.1183/13993003.00407-2017
Year: 2017



Idiopathic pulmonary haemosiderosis revisited
Source: Eur Respir J 2004; 24: 162-169
Year: 2004



Alveolar hemorrhage syndrome in children
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018




Emergencies in interstitial and immunological lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=177
Year: 2006

Pulmonary vasculitis presenting as acute diffuse alveolar haemorrhage (DAH)
Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon
Year: 2018


Pulmonary alveolar proteinosis and idiopathic pulmonary hemosiderosis
Source: International Congress 2019 – CCC Airway diseases
Year: 2019



Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease
Year: 2011

The causes of hemoptysis and lung hemorrhage in patients with pulmonary sarcoidosis
Source: Annual Congress 2011 - Acute respiratory failure
Year: 2011


Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality
Source: Eur Respir J 2010; 35: 1303-1311
Year: 2010



Diffuse alveolar hemorrhage and pulmonary fibrosis in MPO-ANCA-associated vasculitides
Source: Eur Respir J 2005; 26: Suppl. 49, 267s
Year: 2005

Endothelin-1 and pulmonary artery pressures in acute pulmonary exacerbation of cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 416s
Year: 2001

Cytomegalovirus-associated pulmonary exacerbation in patients with cystic fibrosis
Source: ERJ Open Res, 4 (1) 00111-2017; 10.1183/23120541.00111-2017
Year: 2018



Right ventricular dysfunction in pulmonary hypertension with combined pulmonary fibrosis and emphysema syndrome
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Pulmonary veno-occlusive disease and pulmonary capillary haemangiomatosis
Source: Eur Respir Mon 2012; 57: 182-193
Year: 2012


Pulmonary arterial hypertension masquerading as severe refractory asthma
Source: Eur Respir J 2008; 32: 513-516
Year: 2008



Air-leak syndrome caused by pleuroparenchymal fibroelastosis after bone marrow transplantation
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Oxygen therapy decreases systemic inflammation in patients with chronic obstructive pulmonary disease and hypoxemia
Source: Annual Congress 2010 - Novel anti-inflammatory agents for airway disease
Year: 2010


Broncholithiasis as a cause of pulmonary hemorrhages
Source: Eur Respir J 2007; 30: Suppl. 51, 543s
Year: 2007